The Southern District of New York’s chief judge on Tuesday pushed back a high-profile drug patent trial from May to July after lawyers for Ferring Pharmaceuticals Inc. and Serenity Pharmaceuticals LLC expressed concerns about the impact of the COVID-19 pandemic on the proceedings…

Read this piece in its entirety at Law360.